Published in Clin Pharmacol Ther on April 01, 1980
Diuretic treatment of resistant hypertension. Br Med J (1980) 1.12
Relative potency of spironolactone, triamterene and potassium chloride in thiazide-induced hypokalaemia. Br J Clin Pharmacol (1982) 1.04
Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis. Heart Fail Rev (2005) 0.98
Thiazide-induced hypokalaemia; prevalence higher in women. Br J Clin Pharmacol (1984) 0.93
Spironolactone in thiazide-induced hypokalaemia: variable response between patients. Br J Clin Pharmacol (1981) 0.90
Discovery and in Vivo Evaluation of Potent Dual CYP11B2 (Aldosterone Synthase) and CYP11B1 Inhibitors. ACS Med Chem Lett (2013) 0.88
Pharmacokinetics of potassium chloride in wax-based and syrup formulations. Br J Clin Pharmacol (1985) 0.86
A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects. Br J Clin Pharmacol (1993) 0.80
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension. BMJ Open (2015) 0.78
The influence of dietary potassium on the renal tubular effect of hydrochlorothiazide in the rat. Br J Pharmacol (1987) 0.78
Adequacy of twice daily dosing with potassium chloride and spironolactone in thiazide treated hypertensive patients. Br J Clin Pharmacol (1991) 0.77
Proceedings of the British Pharmacological Society. 12-14 September 1990, Belfast. Br J Clin Pharmacol (1991) 0.75
Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects. Br J Clin Pharmacol (1984) 0.75
Diuretic induced hypokalaemia: relationship to dosage interval and plasma aldosterone. Br J Clin Pharmacol (1982) 0.75
Mineralocorticoid Receptor Antagonists for Treatment of Hypertension and Heart Failure. Methodist Debakey Cardiovasc J (2016) 0.75
Progressive hypokalaemia in elderly patients taking three thiazide potassium-sparing diuretic combinations for thirty-six months. Postgrad Med J (1988) 0.75
Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects. J Transl Med (2014) 0.75
Use of a bioassay in healthy men to evaluate diuretic-spironolactone combinations. Br J Clin Pharmacol (1983) 0.75
Relative potency of prorenoate potassium and spironolactone in attenuating diuretic induced hypokalaemia. Br J Clin Pharmacol (1984) 0.75
Proceedings of the British Pharmacological Society, British Pharmacology Section. 18-20 April 1990, Sheffield. Abstracts. Br J Clin Pharmacol (1990) 0.75
TEMPERATURE EFFECT OF POPLITEAL VEIN LIGATION IN THROMBO-ANGIITIS OBLITERANS AND ARTERIOSCLEROSIS. Ann Surg (1928) 28.36
THE EFFECT OF ROENTGEN RAYS ON THE RATE OF GROWTH OF SPONTANEOUS TUMORS IN MICE. J Exp Med (1915) 13.91
Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet (1995) 7.59
Biochemical detection of left-ventricular systolic dysfunction. Lancet (1998) 7.51
THE LYMPHOCYTE IN NATURAL AND INDUCED RESISTANCE TO TRANSPLANTED CANCER : II. STUDIES IN LYMPHOID ACTIVITY. J Exp Med (1915) 5.45
The academic base for general practice: the case for change. BMJ (1993) 5.25
THE PRODUCTION OF LYMPHOMATOSIS IN MICE OF KNOWN GENETIC CONSTITUTION. Science (1938) 4.28
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart (2001) 3.88
Diverticulitis of the Colon. Ann Surg (1946) 3.86
Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart (1999) 3.53
The Treatment of Ileus: As Indicated by Clinical Experience and Experimental Studies. Ann Surg (1932) 3.37
SYMPATHETIC INHIBITION OF THE LARGE INTESTINE IN HIRSCHSPRUNG'S DISEASE. J Clin Invest (1930) 3.29
Local confidential inquiry into avoidable factors in deaths from stroke and hypertensive disease. BMJ (1993) 3.25
A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology (2003) 3.14
Reduced thirst after water deprivation in healthy elderly men. N Engl J Med (1984) 3.13
Lipid-lowering for prevention of coronary heart disease: what policy now? Clin Sci (Lond) (1996) 2.88
Captopril in heart failure. A double blind controlled trial. Br Heart J (1984) 2.85
INTERINNOMINO-ABDOMINAL (HINDQUARTER) AMPUTATION. Ann Surg (1942) 2.81
Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J (1985) 2.74
Oxidation phenotype--a major determinant of metoprolol metabolism and response. N Engl J Med (1982) 2.72
Evaluation of vulneray activity by an open wound procedure in rats. Arch Int Pharmacodyn Ther (1972) 2.70
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment. Heart (1999) 2.69
Investigation of selected patients with hypertension by the rapid-sequence intravenous urogram. Lancet (1992) 2.65
A model for clinical governance in primary care groups. BMJ (1999) 2.44
Pituitary ablation for diabetic retinopathy. Q J Med (1965) 2.34
The Elag-Koln automatic blood pressure recorder. A clinical appraisal. Br Heart J (1977) 2.34
Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet (2007) 2.15
Severe hypotension after first dose of enalapril in heart failure. Br Med J (Clin Res Ed) (1985) 2.14
An Evaluation of Pulmonary Embolism following Intravascular Venous Thrombosis. Ann Surg (1947) 2.11
Vagus nerve stimulation for symptomatic generalized epilepsy: a pilot study. Epilepsia (1998) 2.08
Disordered gastric motor function in diabetes mellitus. Diabetologia (1994) 2.07
Menses and breast cancer: does timing of mammographically directed core biopsy affect outcome? J Surg Oncol (2000) 2.07
Skin tumors following a single application of methylcholanthrene in C57 brown mice. Am J Pathol (1939) 2.04
Clinical evaluation of Dinamap 845 automated blood pressure recorder. Br Heart J (1980) 1.94
Sample size for short-term trials of antihypertensive drugs. Br J Clin Pharmacol (1982) 1.91
Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour. Lancet (1970) 1.90
STUDIES ON THE ACTIVITY OF THE LUMBAR SYMPATHETIC NERVOUS SYSTEM. Ann Surg (1930) 1.83
NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. Eur Respir J (2006) 1.81
Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab (1998) 1.80
Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart (2001) 1.77
Elevated troponin levels are associated with sympathoadrenal activation in acute ischaemic stroke. Cerebrovasc Dis (2006) 1.77
Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J (Clin Res Ed) (1982) 1.76
Circulating dopamine: its effect on the plasma concentrations of catecholamines, renin, angiotensin, aldosterone and vasopressin in the conscious dog. Clin Sci (Lond) (1981) 1.76
A comparison of double-isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man. Clin Sci Mol Med (1973) 1.76
What proportion of patients refuse consent to data collection from their records for research purposes? Br J Gen Pract (2000) 1.74
The lupus syndrome induced by hydralazine: a common complication with low dose treatment. Br Med J (Clin Res Ed) (1984) 1.71
Weight reduction in a blood pressure clinic. Br Med J (1978) 1.67
Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function. Int J Radiat Oncol Biol Phys (2000) 1.64
An assessment of radiological criteria used in the study of spinal osteoporosis. Br J Radiol (1967) 1.62
Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol (2002) 1.61
Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens (1992) 1.60
Chondrosarcoma. Ann Surg (1947) 1.60
Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture. Hypertension (1980) 1.60
Evidence that nitric oxide mechanisms regulate small intestinal motility in humans. Gut (1999) 1.59
Normal insulin response to glucose. Lancet (1966) 1.58
A microassay for active and total renin concentration in human plasma based on antibody trapping. Clin Chim Acta (1980) 1.58
Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol (Oxf) (1992) 1.56
Setting the agenda for multiple sclerosis rehabilitation research. Mult Scler (2008) 1.55
Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing. Br J Clin Pharmacol (1982) 1.55
OBSTRUCTIONS ABOUT THE MESENTERY IN INFANTS. Ann Surg (1936) 1.54
Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. Gut (1994) 1.51
Persistent dry cough with enalapril: incidence depends on method used. J Hum Hypertens (1990) 1.50
Bioassay of aldosterone antagonists in normal human subjects: a relationship between the level of plasma uric acid before treatment and apparent drug responses. Br J Clin Pharmacol (1975) 1.48
Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction. J Am Coll Cardiol (1999) 1.47
Plasma endothelin in chronic heart failure. Circulation (1992) 1.47
Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature (1981) 1.42
Effect of high-dose intravenous eletriptan on coronary artery diameter. Cephalalgia (2004) 1.42
Newborn sickle cell disease screening: the Jamaican experience (1995-2006). J Med Screen (2007) 1.41
Coronary atheroma regression trials. Lancet (1992) 1.40
The Sheffield table for primary prevention of coronary heart disease: corrected. Lancet (1996) 1.40
Antihypertensive and adverse biochemical effects of bendrofluazide. BMJ (1990) 1.39
Value of BNP to estimate cardiac risk in patients on cardioactive treatment in primary care. Eur J Heart Fail (2007) 1.38
A radioimmunoassay for plasma arginine-vasopressin in man and dog: application to physiological and pathological states. J Endocrinol (1975) 1.37
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril. Lancet (1979) 1.37
Liver dysfunction in hypertension. Lancet (1977) 1.35
Ketanserin in essential hypertension: a double-blind, placebo-controlled study. Postgrad Med J (1985) 1.32
Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration. Br Med J (1975) 1.32
Severe hypokalaemia with paralysis induced by small doses of liquorice. Postgrad Med J (1980) 1.29
The Similarity in Effect of Experimental High Intestinal Obstruction and High Complete Intestinal Fistula. Ann Surg (1931) 1.29
Prediction of coronary risk for primary prevention of coronary heart disease: a comparison of methods. QJM (1999) 1.28
Hypersensitivity to pituitary snuff with miliary shadowing in the lungs. Thorax (1967) 1.28
Quantification of side-effects of beta-adrenoceptor blockers using visual analogue scales. Br J Clin Pharmacol (1984) 1.24
Evidence for a contribution of the motor cortex to the long-latency stretch reflex of the human thumb. J Physiol (1991) 1.23
Role and integration of mechanisms controlling gastric emptying. Dig Dis Sci (1994) 1.23
Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers. Clin Pharmacol Ther (1983) 1.22
Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol. Br J Clin Pharmacol (1976) 1.22
Factors influencing serum potassium in treated hypertension. Q J Med (1977) 1.22
Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut (1995) 1.20